abrdn Life Sciences Investors HQL
$22.38 $0.30 (1.36%) 1D
Last Updated: Aug 21, 12:00 AM·NYSE
Pricing for US stocks is delayed by 24 hours
HQL Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, abrdn Life Sciences Investors is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
abrdn Life Sciences Investors. Stock Analysis HQL
United States N/A Small Cap abrdn Life Sciences Investors is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. abrdn Life Sciences Investors (the Fund) is a non-diversified closed-end management investment company. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in equity and related securities of the United States and foreign companies principally engaged in the development, production or distribution of products or services related to scientific advances in life sciences (including biotechnology, pharmaceuticals, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices, supplies and other healthcare-related sub-sectors), agriculture and environmental management (Life Sciences Companies). The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded primarily in foreign markets. The Fund’s investment adviser is abrdn Inc.
abrdn Life Sciences Investors (HQL) Chart
Financial Metrics & Statements of abrdn Life Sciences Investors (HQL)
FAQ's for abrdn Life Sciences Investors (HQL)
- As of August 2026, abrdn Life Sciences Investors HQL is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes abrdn Life Sciences Investors using these criteria to determine its compliance status.
- Muslim investors may consider investing in abrdn Life Sciences Investors if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of abrdn Life Sciences Investors by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of abrdn Life Sciences Investors may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of abrdn Life Sciences Investors on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for abrdn Life Sciences Investors (HQL)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
